Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 123-126, 2011.
Artigo
em Inglês
| WPRIM
| ID: wpr-341445
ABSTRACT
Recombinant human growth hormone is generally safe in treating children with growth hormone deficiency and idiopathic short stature. However, side effects such as sodium and water retention, benign intracranial hypertension, insulin insensitivity, increasing risk of secondary neoplasm, scoliosis, and slipped capital femoral epiphysis may occur occasionally, although the overall incidence remains low.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Proteínas Recombinantes
/
Hormônio do Crescimento Humano
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Nanismo
/
Nanismo Hipofisário
Limite:
Humanos
Idioma:
Inglês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS